59 research outputs found
On the dynamical generation of the Maxwell term and scale invariance
Gauge theories with no Maxwell term are investigated in various setups. The
dynamical generation of the Maxwell term is correlated to the scale invariance
properties of the system. This is discussed mainly in the cases where the gauge
coupling carries dimensions. The term is generated when the theory contains a
scale explicitly, when it is asymptotically free and in particular also when
the scale invariance is spontaneously broken. The terms are not generated when
the scale invariance is maintained. Examples studied include the large
limit of the model in dimensions, a 3D gauged
vector model and its supersymmetric extension. In the latter case the
generation of the Maxwell term at a fixed point is explored. The phase
structure of the case is investigated in the presence of a Chern-Simons
term as well. In the supersymmetric model the emergence of the Maxwell
term is accompanied by the dynamical generation of the Chern-Simons term and
its multiplet and dynamical breaking of the parity symmetry. In some of the
phases long range forces emerge which may result in logarithmic confinement.
These include a dilaton exchange which plays a role also in the case when the
theory has no gauge symmetry. Gauged Lagrangian realizations of the 2D coset
models do not lead to emergent Maxwell terms. We discuss a case where the gauge
symmetry is anomalous.Comment: 38 pages, 4 figures; v2 slightly improved, typos fixed, references
added, published versio
Contrasting prefrontal cortex contributions to episodic memory dysfunction in behavioural variant frontotemporal dementia and alzheimer's disease
Recent evidence has questioned the integrity of episodic memory in behavioural variant frontotemporal dementia (bvFTD), where recall performance is impaired to the same extent as in Alzheimer's disease (AD). While these deficits appear to be mediated by divergent patterns of brain atrophy, there is evidence to suggest that certain prefrontal regions are implicated across both patient groups. In this study we sought to further elucidate the dorsolateral (DLPFC) and ventromedial (VMPFC) prefrontal contributions to episodic memory impairment in bvFTD and AD. Performance on episodic memory tasks and neuropsychological measures typically tapping into either DLPFC or VMPFC functions was assessed in 22 bvFTD, 32 AD patients and 35 age- and education-matched controls. Behaviourally, patient groups did not differ on measures of episodic memory recall or DLPFC-mediated executive functions. BvFTD patients were significantly more impaired on measures of VMPFC-mediated executive functions. Composite measures of the recall, DLPFC and VMPFC task scores were covaried against the T1 MRI scans of all participants to identify regions of atrophy correlating with performance on these tasks. Imaging analysis showed that impaired recall performance is associated with divergent patterns of PFC atrophy in bvFTD and AD. Whereas in bvFTD, PFC atrophy covariates for recall encompassed both DLPFC and VMPFC regions, only the DLPFC was implicated in AD. Our results suggest that episodic memory deficits in bvFTD and AD are underpinned by divergent prefrontal mechanisms. Moreover, we argue that these differences are not adequately captured by existing neuropsychological measures
Recommended from our members
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins.
We believe this is the first study to investigate associations between blood metabolites and neocortical amyloid burden (NAB) in the search for a blood-based biomarker for Alzheimer's disease (AD). Further, we present the first multi-modal analysis of blood markers in this field. We used blood plasma samples from 91 subjects enrolled in the University of California, San Francisco Alzheimer's Disease Research Centre. Non-targeted metabolomic analysis was used to look for associations with NAB using both single and multiple metabolic feature models. Five metabolic features identified subjects with high NAB, with 72% accuracy. We were able to putatively identify four metabolites from this panel and improve the model further by adding fibrinogen gamma chain protein measures (accuracy=79%). One of the five metabolic features was studied in the Alzheimer's Disease Neuroimaging Initiative cohort, but results were inconclusive. If replicated in larger, independent studies, these metabolic features and proteins could form the basis of a blood test with potential for enrichment of amyloid pathology in anti-amyloid trials
Network Analysis of Intrinsic Functional Brain Connectivity in Alzheimer's Disease
Functional brain networks detected in task-free (“resting-state”) functional magnetic resonance imaging (fMRI) have a small-world architecture that reflects a robust functional organization of the brain. Here, we examined whether this functional organization is disrupted in Alzheimer's disease (AD). Task-free fMRI data from 21 AD subjects and 18 age-matched controls were obtained. Wavelet analysis was applied to the fMRI data to compute frequency-dependent correlation matrices. Correlation matrices were thresholded to create 90-node undirected-graphs of functional brain networks. Small-world metrics (characteristic path length and clustering coefficient) were computed using graph analytical methods. In the low frequency interval 0.01 to 0.05 Hz, functional brain networks in controls showed small-world organization of brain activity, characterized by a high clustering coefficient and a low characteristic path length. In contrast, functional brain networks in AD showed loss of small-world properties, characterized by a significantly lower clustering coefficient (p<0.01), indicative of disrupted local connectivity. Clustering coefficients for the left and right hippocampus were significantly lower (p<0.01) in the AD group compared to the control group. Furthermore, the clustering coefficient distinguished AD participants from the controls with a sensitivity of 72% and specificity of 78%. Our study provides new evidence that there is disrupted organization of functional brain networks in AD. Small-world metrics can characterize the functional organization of the brain in AD, and our findings further suggest that these network measures may be useful as an imaging-based biomarker to distinguish AD from healthy aging
Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy
Posterior cortical atrophy is a clinico-radiological syndrome characterized by progressive decline in visual processing and atrophy
of posterior brain regions. With the majority of cases attributable to Alzheimer’s disease and recent evidence for genetic risk factors
specifically related to posterior cortical atrophy, the syndrome can provide important insights into selective vulnerability and
phenotypic diversity. The present study describes the first major longitudinal investigation of posterior cortical atrophy disease
progression. Three hundred and sixty-one individuals (117 posterior cortical atrophy, 106 typical Alzheimer’s disease, 138 controls) fulfilling consensus criteria for posterior cortical atrophy-pure and typical Alzheimer’s disease were recruited from three
centres in the UK, Spain and USA. Participants underwent up to six annual assessments involving MRI scans and neuropsychological testing. We constructed longitudinal trajectories of regional brain volumes within posterior cortical atrophy and typical
Alzheimer’s disease using differential equation models. We compared and contrasted the order in which regional brain volumes
become abnormal within posterior cortical atrophy and typical Alzheimer’s disease using event-based models. We also examined
trajectories of cognitive decline and the order in which different cognitive tests show abnormality using the same models.
Temporally aligned trajectories for eight regions of interest revealed distinct (P5 0.002) patterns of progression in posterior
cortical atrophy and typical Alzheimer’s disease. Patients with posterior cortical atrophy showed early occipital and parietal
atrophy, with subsequent higher rates of temporal atrophy and ventricular expansion leading to tissue loss of comparable
extent later. Hippocampal, entorhinal and frontal regions underwent a lower rate of change and never approached the extent
of posterior cortical involvement. Patients with typical Alzheimer’s disease showed early hippocampal atrophy, with subsequent
higher rates of temporal atrophy and ventricular expansion. Cognitive models showed tests sensitive to visuospatial dysfunction
declined earlier in posterior cortical atrophy than typical Alzheimer’s disease whilst tests sensitive to working memory impairment
declined earlier in typical Alzheimer’s disease than posterior cortical atrophy. These findings indicate that posterior cortical atrophy
and typical Alzheimer’s disease have distinct sites of onset and different profiles of spatial and temporal progression. The ordering
of disease events both motivates investigation of biological factors underpinning phenotypic heterogeneity, and informs the selection of measures for clinical trials in posterior cortical atrophy
- …